Action and Impact: Prevention and Screening Strategies Contributing to the Elimination of Cervical Cancer
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Gynecologic Oncology".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 415
Special Issue Editor
2. Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada
Interests: psychosocial oncology; HPV; cervical cancer; vaccine decision-making; cancer prevention; vaccine hesitancy; COVID-19
Special Issue Information
Dear Colleagues,
Cervical cancer is a preventable public health problem. Currently, it is one of the only cancers that has a clear preventable cause, the human papillomavirus (HPV). There are several HPV vaccines; they are safe and effective in preventing cervical cancer. We can also screen for cervical cancer using safe, effective and inexpensive methods, e.g., HPV DNA testing. Although we have the tools available to eliminate cervical cancer, one woman dies every two minutes from this disease worldwide.
For this Special Issue, we are pleased to invite you to submit original research articles and commentaries related to the behavioural and implementation sciences of HPV vaccination and/or screening practices that are contributing to the goal of eliminating cervical cancer. We welcome articles that examine ways to increase acceptability or projects that were able to increase knowledge, or modify behaviours related to cervical cancer prevention practices. This Special Issue focuses on the behavioural and implementation sciences i.e., the knowledge, attitudes and beliefs of HPV vaccine acceptability, HPV vaccine hesitancy, the acceptability, knowledge and attitudes of women towards HPV and HPV self-sampling. This includes actionable suggestions or examples, e.g., the implementation of new programs, health care provider (physicians, dentists, nurses and allied health professionals) communication strategies and interventions to increase the acceptability of health behaviours that will lead toward the attainable goal of cervical cancer elimination.
I look forward to receiving your contributions.
Dr. Samara Perez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV vaccine acceptability
- cervical cancer health behaviours
- implementation sciences
- behavioural sciences
